SDS Table of Contents Click the desired link below to jump directly to that section in the SDS. MATERIAL SAFETY DATA SHEET MSDS #: 210 LATEST REVISION: MAY 2008 SELECTRODE INDUSTRIES, INC.
1.1 PRODUCT NAME: COATED ELECTRODES: 1139, 1142, AND 1144 1.2 MANUFACTURER: SELECTRODE INDUSTRIES, INC. 230 BROADWAY HUNTINGTON STATION, NY 11746 U.S.A. PHONE: 631-547-5470 FAX: 631-547-5475 E-MAIL: INFO@SELECTRODE.COM 1.3 EMERGENCY TELEPHONE NUMBER: 631-547-5470
PREPARATION: CORE WIRE: NICKEL IRON HAZARDOUS INGREDIENTS: IMPORTANT: THIS SECTION COVERS THE MATERIALS OF WHICH THE PRODUCTS ARE MANUFACTURED. THE FUMES AND GASES PRODUCED DURING NORMAL USE OF THIS PRODUCT ARE COVERED IN SECTION 3. THE TERM "HAZARDOUS" IN "HAZARDOUS MATERIAL" SHOULD BE INTERPRETED AS A TERM REQUIRED AND DEFINED IN OSHA HAZARD COMMUNICATION STANDARD 29 CFR 1910-1200 AND IT DOES NOT NECESSARILY IMPLY THE EXISTENCE OF HAZARD. THE CHEMICALS OR COMPOUNDS REPORTABLE BY SECTION 313 OF SARA ARE MARKED BY THE SYMBOL #. INGREDIENTS CAS# % RANGE CALCIUM CARBONATE 1317-65-3 1-11 GRAPHITE 7782-42-5 1-11 POTASSIUM SILICATE 1312-76-1 1-11 SODIUM SILICATE 1344-09-8 1-11 ALUMINIUM 7429-90-5 1-11 CALCIUM FLUORIDE 7789-75-5 1-11 NICKEL 7440-02-0 35-50 IRON 7439-89-6 32-47 INGREDIENTS OSHA PEL ACGIH-TLV CARCINOGENICITY R-PHASE MG/M3 MG/M3 CALCIUM CARBONATE 5 (Ca O) 10 NO GRAPHITE NOT REGSTRD. 5 NO POTASSIUM SILICATE NOT REGSTRD. 5 NO SODIUM SILICATE NOT REGSTRD. 5 NO ALUMINIUM 5 (AS FUME) 5 (AS FUME) NO CALCIUM FLUORIDE 2.5 2.5 NO (AS FUME) (AS FUME) NICKEL 1 1 YES R40, R43 IRON 10 (AS Fe) 5 (AS Fe) NO
EFFECTS OF ACUTE EXPOSURE: ROUTE(S) OF ENTRY: INHALATION AND SKIN CONTACT. EYE AND SKIN: WHEN WELDING, ARC RAYS CAN INJURE EYES AND BURN SKIN INHALATION: EXPOSURE TO NICKEL CONTAINING DUST AND WELDING FUMES, MAY CAUSE IRRITATION TO UPPER RESPIRATORY TRACT. MAY CAUSE RESPIRATORY SENSITIZATION IN SUSCEPTIBLE INDIVIDUALS. REASONABLE EXPECTED DECOMPOSITION PRODUCTS FROM NORMAL USE OF THESE PRODUCTS INCLUDE A COMPLEX OF THE OXIDES OF THE MATERIALS LISTED IN SECTION 2, AS WELL AS CARBON MONOXIDE, CARBON DIOXIDE, OZONE, AND NITROGEN OXIDES (REFER TO "CHARACTERIZATION OF ARC WELDING FUME" AVAILABLE FROM THE AMERICAN WELDING SOCIETY). THE TLV FOR MANGANESE (0.02 MG/M3) WILL BE REACHED BEFORE THE GENERAL LIMIT FOR WELDING FUMES OF 5 MG/M3 IS REACHED. MONITOR FUMES FOR MAGANESE LEVELS. THE ONLY WAY TO DETERMINE THE TRUE IDENTITY OF THE DECOMPOSITION PRODUCTS IS BY SAMPLING AND ANALYSIS. THE COMPOSITION AND QUANTITY OF THE FUMES AND GASES TO WHICH A WORKER MAY BE OVEREXPOSED CAN BE DETERMINED FROM A SAMPLE OBTAINED FROM INSIDE THE WELDER'S HELMET, IF WORN, OR IN THE WORKER'S BREATHING ZONE. SEE ANSI/AWS F1.1 "METHOD FOR SAMPLING AIRBORNE PARTICLES GENERATED BY WELDING AND ALLIED PROCESSES." AVAILABLE FROM THE AMERICAN WELDING SOCIETY. INGESTION: AMOUNTS INGESTED INCIDENTAL TO INDUSTRIAL HANDLING ARE NOT LIKELY TO CAUSE INJURY. SINGLE DOSE ORAL TOXICITY IS LOW. EFFECTS OF CHRONIC EXPOSURE: REFER TO SECTION 11 FOR SPECIFIC TOXICOLOGICAL INFORMATION.
INHALATION: REMOVE VICTIM TO FRESH AIR IF EFFECTS OCCUR. SKIN: WASH OFF WITH SOAP AND PLENTY OF WATER. EYES: IRRIGATE WITH WATER FOR SEVERAL MINUTES. INGESTION: RINSE MOUTH. NOTE TO PHYSICIAN: NO PARTICULAR ADVICE.
MEANS OF EXTINGUISHING: NO DANGER REQUIRING SPECIAL MEASURES. SPECIAL PROTECTIVE EQUIPMENT WHEN FIGHTING FIRE: NONE.
INDIVIDUAL PRECAUTIONS: AVOID DUST FORMATION/BREATHING DUST. ENVIRONMENT PROTECTION PRECAUTIONS: NO PARTICULAR INDICATIONS. CLEANING MEASURES: REMOVE SPOILED PRODUCT MECHANICALLY.
7.1 HANDLING: WITH STANDARD TRANSPORTATION EQUIPMENT. 7.2 STORAGE: STORE IN A DRY PLACE IN CLOSED PACKAGES.
TECHNICAL MEASURES: USE ADEQUATE LOCAL EXHAUST FOR WELDING FUMES. AVOID GRINDING DUST INHALATION EXPOSURE LIMITS: SEE SECTION 2. PERSONAL PROTECTION: RESPIRATORY PROTECTION: USE AN AIR PURIFYING DUST RESPIRATOR. HANDS PROTECTION: WEAR APPROPRIATE GLOVES TO PREVENT SKIN CONTACT. EYES PROTECTION: WELDER'S HELMETS. SKIN PROTECTION: WEAR APPROPRIATE OVERALLS TO PREVENT SKIN OR BODY CONTACT.
PHYSICAL STATE: SOLID. ODOR: NONE pH: NON APPLICABLE MELTING POINT: 1830-2730 DEG. F 1000-1500 DEG. C RELATIVE DENSITY: 5-8 G/CM3 SOLUBILITY: INSOLUBLE IN WATER
STABILITY: CONDITIONS TO AVOID: NOT APPLICABLE. MATERIALS TO AVOID: REACTS WITH ACIDS. HAZARDOUS DECOMPOSITION PRODUCTS: UNKNOWN.
EFFECTS OF ACUTE EXPOSURE: TOXICITY TO ANIMALS: VALUES LD/LC50 NICKEL: >9000 MG/KG LOCAL EFFECTS: NOT APPLICABLE. INHALATION: NOT APPLICABLE FOR THE PRODUCT. FOR WELDING FUMES SEE SECTION 3. INGESTION: NOT APPLICABLE. CONTACT WITH SKIN: MAY CAUSE DERMATITIS IN SENSITISED INDIVIDUALS. CARCINOGENICITY: METALLIC NICKEL AND CERTAIN NICKEL ALLOYS ARE CLASSIFIED POSSIBLY CARCINOGENIC TO HUMANS, BASED ON INADEQUATE EVIDENCE OF EFFECTS IN HUMANS. WHILE EPIDEMIOLOGY STUDIES HAVE DEMONSTRATED AN INCREASED RISK OF NASAL, LUNG, AND POSSIBLE RISK OF LARYNGEAL CANCER, THE MOST LIKELY CAUSATIVE AGENTS WERE NICKEL SUBSULFIDE, NICKEL SULFIDE AND NICKEL OXIDE, WITH CANCER LINKED PRINCIPALLY TO THE NICKEL REFINING PROCESS OF ROASTING NICKEL SULPHIDE ORES AND NOT TO METALLIC NICKEL ITSELF. EVIDENCE IMPLICATING METALLIC NICKEL AND NICKEL ALLOYS, OR THE HYDROMETALLURGICAL NICKEL REFINING PROCESS AS RESPIRATORY CARCINOGENS FOR HUMANS IS LACKING. COHORT MORTALITY STUDIES OF WORKERS IN INDUSTRIES IN WHICH EXPOSURE WAS LIMITED TO METALLIC NICKEL OR THE HYDROMETALLURGICAL PROCESS FOUND NO ASSOCIATION BETWEEN EXPOSURE TO METALLIC NICKEL AND ITS ALLOYS TO THE SUBSEQUENT DEVELOPMENT OF RESPIRATORY CANCER. EFFECTS OF CHRONIC (LONG-TERM) OVEREXPOSURE TO AIR CONTAMINANTS MAY LEAD TO THEIR ACCUMULATION IN THE LUNGS, A CONDITION WHICH MAY BE SEEN AS DENSE AREAS ON CHEST X-RAYS. THE SEVERITY OF THE CHANGE IS PROPORTIONAL TO THE LENGTH OF EXPOSURE. THE CHANGES SEEN ARE NOT NECESSARILY ASSOCIATED WITH SYMPTOMS OR SIGNS OF REDUCED LUNG FUNCTION OR DISEASE. IN ADDITION, THE CHANGES ON X-RAYS MAY BE CAUSED BY NON-WORK FACTORS SUCH AS SMOKING, ETC. NICKEL AND CHROMIUM (IN SOME PRODUCTS) ARE CONSIDERED CARCINOGENIC. LONG TERM OVEREXPOSURE TO NICKEL FUMES MAY ALSO CAUSE PULMONARY FIBROSIS AND EDEMA. OVEREXPOSURE TO MANGANESE COMPOUNDS MAY AFFECT THE CENTRAL NERVOUS SYSTEM, SYMPTOMS OF WHICH ARE LANGUOR, SLEEPINESS, MUSCULAR WEAKNESS, EMOTIONAL DISTURBANCES, AND SPASTIC GAIT. THE EFFECT OF MANGANESE ON THE NERVOUS SYSTEM IS IRREVERSIBLE.
ABOUT PRODUCT: DATA ARE UNKNOWN ABOUT INGREDIENTS: DATA ARE UNKNOWN.
PRODUCT: FOR PRODUCT ELIMINATION, CONSULT RECYCLING COMPANIES OR APPROPRIATE LOCAL AUTHORITY. PACKAGE: MAY BE DISPOSED IN APPROVED LANDFILLS PROVIDED LOCAL REGULATIONS ARE OBSERVED.
INTERNATIONAL REGULATIONS: LAND SHIPMENT: NO HAZARD RAIL / ROUTE (RID/ADR): SEA SHIPMENT: NO HAZARD SHIPMENT BY AIR: NO HAZARD
LABEL CEE: NOT NECESSARY DANGER SYMBOLS AND INDICATIONS: Xn R-PHRASES: R40: R43: S-PHRASES: S22: S36:
THE INFORMATION IN THIS DOCUMENT IS BELIEVED TO BE CORRECT AS OF THE DATE ISSUED. HOWEVER, NO WARRANTY IS EXPRESSED TO BE IMPLIED REGARDING THE ACCURACY OR COMPLETENESS OF THIS INFORMATION. THIS INFORMATION AND PRODUCT ARE FURNISHED ON THE CONDITION THAT THE PERSON RECEIVING THEM SHALL MAKE HIS OWN DETERMINATIONS AS TO THE SUITABILITY OF THE PRODUCT FOR HIS PARTICULAR PURPOSE AND ON THE CONDITION THAT HE ASSUME THE RISK OF HIS USE THEREOF. THIS MATERIAL SAFETY DATA SHEET COMPLIES WITH THE EC DIRECTIVES 91/155/EEC AND 93/112/EEC INCLUDING MODIFICATIONS 2001/58/EC. COMPLIES WITH OSHA COMMUNICATION STANDARD 29 CFR 1910.1200 AND SUPERFUND AMENDMENTS AND REAUTHORIZATION ACT (SARA) OF 1986 PUBLIC LAW 99-499 |